scholarly journals Assessment of Quality of Life in Patients with Chronic Kidney Disease on Maintenance Haemodialysis with Regard to Anaemia - A Descriptive Cross-Sectional Study at a Tertiary Hospital in Kuppam

2021 ◽  
Vol 8 (21) ◽  
pp. 1636-1641
Author(s):  
Uma M.A ◽  
Nagakiran K.V ◽  
Ashwin K ◽  
Lakshmi Visruja R

BACKGROUND Anaemia is common among chronic kidney disease (CKD) patients. Quality of life (QOL) is a broad multidimensional concept and many factors affect QOL in CKD patients. This study attempted to measure QOL with varying levels of haemoglobin in CKD patients. METHODS The present study was a descriptive cross-sectional study done on CKD patients on maintenance haemodialysis (MHD) after ethical committee approval. All patients aged more than 18 years on MHD for at least 3 months were enrolled in the study. Patients were categorised into 4 separate groups as Hb 4 to < 6 g/dl, 6 to < 8 g/dl, 8 to < 10 g/dl and 10 - 12 g/dl. After obtaining informed consent, participants were given the study questionnaire - kidney disease quality of life (KDQOL) short form (SF - 36) TM V1 .2. RESULTS At different Hb levels, there were significant differences in the kidney symptom/ problem scores (P = 0.000),the burden of kidney disease scores (P = 0.000), the work satisfaction scores (P = 0.014) and the cognitive function scores (P = 0.000). About SF - 36, all of the physical domains were significantly different: physical function scores (P = 0.000), role physical scores (P = 0.045), pain scores (P = 0.000) and general health component scores (P = 0.004) at different Hb levels. For mental domain components, the differences between four groups of Hb levels were significant in the variety of quality of life domains: emotional wellbeing score (P = 0.006), role emotion scores (0.000), social function scores (P = 0.000) and energy/fatigue scores (0.026). CONCLUSIONS KDQOL, SF - 36 showed that the QOL scores are strongly related to Hb concentrations. The higher scores in various quality of life domains were mostly associated with higher Hb levels in the KDQOL - SF scores. Efforts to optimize haemoglobin in CKD patients may show QOL improvement. KEYWORDS Chronic Kidney Disease, Haemodialysis, Anaemia, Quality of Life

2020 ◽  
Vol 17 (18) ◽  
pp. 2954-2963
Author(s):  
Jakub Ruszkowski ◽  
Zbigniew Heleniak ◽  
Ewa Król ◽  
Agnieszka Tarasewicz ◽  
Joanna Gałgowska ◽  
...  

2017 ◽  
Vol 30 (4) ◽  
pp. 781-788 ◽  
Author(s):  
Jefferson Belarmino Nunes Barbosa ◽  
Elaine Cristina Santa Cruz de Moura ◽  
Celine Lorena Oliveira Barboza de Lira ◽  
Patrícia Érika de Melo Marinho

Abstract Introduction: Quality of life (QoL) of hemodialysis patients is a major evaluative marker currently measured, while treatment time is a clinical determinant associated with impaired QOL. Objective: To evaluate QOL in individuals undergoing hemodialysis (HD) considering treatment time and the presence of comorbidities. Methods: A cross-sectional study conducted in the hemodialysis unit of the Hospital das Clínicas da Universidade Federal de Pernambuco (HC-UFPE). We studied patients with Chronic Kidney Disease (CKD) of both genders over the age of 18 years, at any level of education and undergoing HD for at least 6 months. We evaluated the demographic/socioeconomic and clinical data, followed by application of the quality of life questionnaire (KDQOL-SF). Results: Participants were 47 patients with a mean age of 50.94 ± 13.33 years, 55.3% were male and average treatment time of 57.35 ± 61.46 months. Hypertension (59.6%) was the most frequent underlying disease. According to the responses obtained through the KDQOL-SF, the situation at work and physical limitation scored worse. Sexual function (85.83) and encouragement by the team had the best performance. There were no differences in dimensions of questionnaire and treatment time. Conclusion: The presence of comorbidities and HD duration were not found to be possible factors for changing QoL in this study. However, we suggest that future studies evaluate other factors such as laboratory, emotional and functional data to check for changes in QoL in these patients related to HD duration.


Author(s):  
Shambhu Kumar Saxena Mahato ◽  
Tawatchai Apidechkul ◽  
Pamornsri Sriwongpan ◽  
Rajani Hada ◽  
Guna Nidhi Sharma ◽  
...  

2014 ◽  
Vol 12 (1) ◽  
pp. 27 ◽  
Author(s):  
Henrique Mansur ◽  
Fernando AB Colugnati ◽  
Fabiane Rossi dos Santos Grincenkov ◽  
Marcus Bastos

Author(s):  
Beatriz dos Santos Pereira ◽  
Neimar da Silva Fernandes ◽  
Nayara Pires de Melo ◽  
Renata Abrita ◽  
Fabiane Rossi dos Santos Grincenkov ◽  
...  

2011 ◽  
Vol 12 (1) ◽  
Author(s):  
Anna Kaltsouda ◽  
Petros Skapinakis ◽  
Dimitrios Damigos ◽  
Margarita Ikonomou ◽  
Rigas Kalaitzidis ◽  
...  

2020 ◽  
Vol 8 (3) ◽  
pp. 797-801
Author(s):  
Maria Pauly ◽  
Uday Venkat Mateti ◽  
Pradeep Shenoy ◽  
Neethu Saj ◽  
Malona Lilly Philip

Sign in / Sign up

Export Citation Format

Share Document